OHSU leadership on stage at AACR
Dozens of OHSU Knight Cancer Institute researchers commanded the spotlight at the American Association for Cancer Research Annual Meeting in Orlando, Florida. Lisa Coussens, Ph.D., who concluded...
Dozens of OHSU Knight Cancer Institute researchers commanded the spotlight at the American Association for Cancer Research Annual Meeting in Orlando, Florida. Lisa Coussens, Ph.D., who concluded...
Cancer clinical trials that use less-reliable shortcut endpoints save relatively little time, according to an analysis of 107 cancer drugs approved for 188 indications from 2006 to 2017. Image:...
More than half of cancer drugs approved in recent years may not be helping patients to live longer. Meanwhile, the average price of cancer drugs has been increasing by 10 percent annually for more...
When reviewers with the Food and Drug Administration weigh the evidence for a drug company's experimental treatment, how many are thinking: I may someday work for that company? It's a difficult...
Speakers who nominally represent cancer patients at advisory meetings on new drugs often have financial ties with the company seeking marketing approval. And those ties aren’t always disclosed,...